IL-17 Inhibitors and the Risk of Malignancy. Can Dermatol Today [Internet]. 2022 Mar. 1 [cited 2026 Sep. 17];3(1):18–21. Available from: https://canadiandermatologytoday.com/article/view/3-1-mak